Powered by OpenAIRE graph
Found an issue? Give us feedback
image/svg+xml art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos Open Access logo, converted into svg, designed by PLoS. This version with transparent background. http://commons.wikimedia.org/wiki/File:Open_Access_logo_PLoS_white.svg art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos http://www.plos.org/ ZENODOarrow_drop_down
image/svg+xml art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos Open Access logo, converted into svg, designed by PLoS. This version with transparent background. http://commons.wikimedia.org/wiki/File:Open_Access_logo_PLoS_white.svg art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos http://www.plos.org/
ZENODO
Article . 2022
License: CC BY
Data sources: Datacite
image/svg+xml art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos Open Access logo, converted into svg, designed by PLoS. This version with transparent background. http://commons.wikimedia.org/wiki/File:Open_Access_logo_PLoS_white.svg art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos http://www.plos.org/
ZENODO
Article . 2022
License: CC BY
Data sources: Datacite
image/svg+xml art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos Open Access logo, converted into svg, designed by PLoS. This version with transparent background. http://commons.wikimedia.org/wiki/File:Open_Access_logo_PLoS_white.svg art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos http://www.plos.org/
ZENODO
Article . 2022
License: CC BY
Data sources: ZENODO
versions View all 2 versions
addClaim

This Research product is the result of merged Research products in OpenAIRE.

You have already added 0 works in your ORCID record related to the merged Research product.

COMPARATIVE STUDY OF DIFFERENT BRANDS OF RESPERIDONE MARKETED FORMULATION

Authors: Karan rajak, Mahendra kumar Sharma, kripal gurjar, Mahendra thakur, Madiha khan, Dr. Jagdish rathi, Pooja Malviya, Rahul sharma;

COMPARATIVE STUDY OF DIFFERENT BRANDS OF RESPERIDONE MARKETED FORMULATION

Abstract

The proposed method for the determination of resperidone in solid dosage form was found to be precise, Selective, rapid and economical.The proposed methods can be used for the drug analysis in routine quality control & method proves to be More economical than the published Standard methods. resperidone is a safe and effective new antipsychotic that has a high binding affinity for both serotonin and dopamine receptors.1 Several well-designed controlled clinical trials have been conducted to establish the antipsychotic efficacy of resperidone. In a previously published report we had mentioned the rationale for using a once-a-day dosage schedule for resperidone based on the elimination half-life of resperidone and its active metabolite, 9-hydroxyresperidone, to enhance compliance. Since that time, the use of resperidone once daily has been studied and recommended. In the setting of a community day treatment program, we had switched patients from a twice-a-day resperidone dosage schedule to a once-daily dosage and found it to be effective. In a retrospective chart review published earlier, we found no increase in side effects such as neuroleptic-induced extrapyramidal symptoms or sedation in patients taking once-daily resperidone. We found the once-daily dosage to be safe, and patient compliance was enhanced. We now report a retrospective chart review of patients who had been on once-daily resperidone treatment for an extended period of time. The aim of this study was to assess the efficacy, extrapyramidal side effects, and tolerability of resperidone in these patients over an extended period of time. The Food and Drug Administration (FDA)-approved indications for oral resperidone (tablets & oral solution) include the treatment of schizophrenia (in adults and children aged 13 and up), bipolar acute manic or mixed episodes as monotherapy (in adults and children aged 10 and up), bipolar acute manic or mixed episodes adjunctive with lithium or valproate (in adults), and autism- associated irritability (in children aged 5 and up). Also, the long-acting resperidone injection has been approved for the use of schizophrenia and maintenance of bipolar disorder (as monotherapy or adjunctive to valproate or lithium) in adults. There are also many varied non-FDA-approved uses for resperidone. This activity outlines the indications, mechanism of action, administration methods, significant adverse effects, contraindications, and monitoring, of resperidone, so providers can direct patient therapy in treating conditions for which it is indicated as part of the inter professional team. KEYWORDS: Hardness, Friability, Thickness, Friability, brand

  • BIP!
    Impact byBIP!
    citations
    This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
    0
    popularity
    This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.
    Average
    influence
    This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
    Average
    impulse
    This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.
    Average
    OpenAIRE UsageCounts
    Usage byUsageCounts
    visibility views 14
    download downloads 10
  • 14
    views
    10
    downloads
    Powered byOpenAIRE UsageCounts
Powered by OpenAIRE graph
Found an issue? Give us feedback
visibility
download
citations
This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
BIP!Citations provided by BIP!
popularity
This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.
BIP!Popularity provided by BIP!
influence
This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
BIP!Influence provided by BIP!
impulse
This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.
BIP!Impulse provided by BIP!
views
OpenAIRE UsageCountsViews provided by UsageCounts
downloads
OpenAIRE UsageCountsDownloads provided by UsageCounts
0
Average
Average
Average
14
10
Green
Related to Research communities